Suppression of FGF signaling: A putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma

Gastroenterology

Volumn 128, Issue 1, 2005, Pages 228-231

  Wang, Lihua ^a   Levin, Marc S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St L ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FIBROBLAST GROWTH FACTOR; GLYCYRRHIZIC ACID; INTERFERON; LINOLENIC ACID; MEGESTROL; PRAVASTATIN; RETINOID DERIVATIVE; TAMOXIFEN;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE SEVERITY; DONOR; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; HEPATITIS; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL TIME; TRANSCRIPTION REGULATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 11144305085     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.11.047     Document Type: Editorial

References (45)

1. H.B. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
2. N. Ince, J.R. Wands The increasing incidence of hepatocellular carcinoma N Engl J Med 340 1999 798 799
3. S.D. Ryder Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults Gut 52 Suppl 3 2003 iii1 iii8
4. A. Sangiovanni, E. Del Ninno, P. Fasani, C. De Fazio, G. Ronchi, R. Romeo, A. Morabito, R. De Franchis, M. Colombo Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 2004 1005 1014
5. A. Befeler, A. di Bisceglie Hepatocellular carcinoma diagnosis and treatment Gastroenterology 122 2002 1609 1619
6. J.C. Cheng, V.P. Chuang, S.H. Cheng, A.T. Huang, Y.M. Lin, T.I. Cheng, P.S. Yang, D.L. You, J.J. Jian, S.Y. Tsai, J.L. Sung, C.F. Horng Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma Int J Radiat Oncol Biol Phys 47 2000 435 442
7. K. Ohnishi, H. Yoshioka, S. Ito, K. Fujiwara Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma Hepatology 27 1998 67 72
8. D. Sudan, R. Sudan, D. Schafer, A. Langnas Without victory there is no survival transarterial lipiodol chemoembolization and hepatocellular carcinoma Hepatology 28 1998 270 271
9. A.K. Nowak, P.K. Chow, M. Findlay Systemic therapy for advanced hepatocellular carcinoma a review Eur J Cancer 40 2004 1474 1484
10. Nowak AK, Findlay M, Culjak G, Stockler M. Tamoxifen for hepatocellular carcinoma. The Cochrane Database of Systematic Reviews 2004:Art. No.:CD001024.pub2. DOI: 10.1002/14651858.
11. N. Ganne-Carrie, J.C. Trinchet Systemic treatment of hepatocellular carcinoma Eur J Gastroenterol Hepatol 16 2004 275 281
12. A. Kasahara, N. Hayashi, K. Mochizuki, M. Takayanagi, K. Yoshioka, S. Kakumu, A. Iijima, A. Urushihara, K. Kiyosawa, M. Okuda, K. Hino, K. Okita Osaka Liver Disease Study Group Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C Hepatology 27 1998 1394 1402
13. L. Blendis Surveillance plus chemoprevention in cirrhotic patients with HCV a better outlook for HCC? Gastroenterology 127 2004 1270 1271
14. Simonetti R, Gluud C, Pagliaro L. Interferon for hepatocellular carcinoma. The Cochrane Database of Systematic Reviews 2002:Art. No.: CD003883.
15. J.R. Wands Prevention of hepatocellular carcinoma N Engl J Med 351 2004 1567 1570
16. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, H. Yuen, T. Tanwandee, Q.M. Tao, K. Shue, O.N. Keene, J.S. Dixon, D.F. Gray, J. Sabbat Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
17. Y. Arase, K. Ikeda, N. Murashima, K. Chayama, A. Tsubota, I. Koida, Y. Suzuki, S. Saitoh, M. Kobayashi, H. Kumada The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1997 1494 1500
18. S. Kojima, M. Okuno, R. Matsushima-Nishiwaki, S.L. Friedman, H. Moriwaki Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review) Int J Oncol 24 2004 797 805
19. C. Clemente, S. Elba, G. Buongiorno, P. Berloco, V. Guerra, A. Di Leo Serum retinol and risk of hepatocellular carcinoma in patients with Child-Pugh class A cirrhosis Cancer Lett 178 2002 123 129
20. K. Sano, T. Takayama, K. Murakami, I. Saiki, M. Makuuchi Overexpression of retinoic acid receptor alpha in hepatocellular carcinoma Clin Cancer Res 9 2003 3679 3683
21. A. Yanagitani, S. Yamada, S. Yasui, T. Shimomura, R. Murai, Y. Murawaki, K. Hashiguchi, T. Kanbe, T. Saeki, M. Ichiba, Y. Tanabe, Y. Yoshida, S. Morino, A. Kurimasa, N. Usuda, H. Yamazaki, T. Kunisada, H. Ito, G. Shiota Retinoic acid receptor alpha dominant negative form causes steatohepatitis and liver tumors in transgenic mice Hepatology 40 2004 366 375
22. S. Adachi, M. Okuno, R. Matsushima-Nishiwaki, Y. Takano, S. Kojima, S.L. Friedman, H. Moriwaki, Y. Okano Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma Hepatology 35 2002 332 340
23. R. Matsushima-Nishiwaki, M. Okuno, S. Adachi, T. Sano, K. Akita, H. Moriwaki, S.L. Friedman, S. Kojima Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma Cancer Res 61 2001 7675 7682
24. Y. Muto, H. Moriwaki, M. Omori In vitro binding affinity of novel synthetic polyprenoids (polyprenoic acids) to cellular retinoid-binding proteins Gann 72 1981 974 977
25. Y. Muto, H. Moriwaki Antitumor activity of vitamin A and its derivatives J Natl Cancer Inst 73 1984 1389 1393
26. N. Nakamura, Y. Shidoji, Y. Yamada, H. Hatakeyama, H. Moriwaki, Y. Muto Induction of apoptosis by acyclic retinoid in the human hepatoma-derived cell line, HuH-7 Biochem Biophys Res Commun 207 1995 382 388
27. H. Moriwaki, Y. Muto, M. Ninomiya, K. Kawai, Y. Suzuki, T. Seto Inhibitory effects of synthetic acidic retinoid and polyprenoic acid on the development of hepatoma in rats induced by 3′-methyl-N, N-dimethyl-4-aminoazobenzene Gastroenterol Jpn 23 1988 546 552
28. Y. Muto, H. Moriwaki, M. Ninomiya, S. Adachi, A. Saito, K.T. Takasaki, T. Tanaka, K. Tsurumi, M. Okuno, E. Tomita, T. Nakamura, T. Kojima Hepatoma Prevention Study Group Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma N Engl J Med 334 1996 1561 1567
29. Y. Muto, H. Moriwaki, A. Saito Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma N Engl J Med 340 1999 1046 1047
30. R. Matsushima-Nishiwaki, M. Okuno, Y. Takano, S. Kojima, S.L. Friedman, H. Moriwaki Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid Carcinogenesis 24 2003 1353 1359
31. I. Yasuda, Y. Shiratori, S. Adachi, A. Obora, M. Takemura, M. Okuno, Y. Shidoji, M. Seishima, Y. Muto, H. Moriwaki Acyclic retinoid induces partial differentiation, down-regulates telomerase reverse transcriptase mRNA expression and telomerase activity, and induces apoptosis in human hepatoma-derived cell lines J Hepatol 36 2002 660 671
32. M. Suzui, M. Shimizu, M. Masuda, J.T. Lim, N. Yoshimi, I.B. Weinstein Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells Mol Cancer Ther 3 2004 309 316
33. M. Suzui, M. Masuda, J.T. Lim, C. Albanese, R.G. Pestell, I.B. Weinstein Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1 Cancer Res 62 2002 3997 4006
34. M. Kagawa, T. Sano, N. Ishibashi, M. Hashimoto, M. Okuno, H. Moriwaki, R. Suzuki, H. Kohno, T. Tanaka An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation Carcinogenesis 25 2004 979 985
35. N. Nakamura, Y. Shidoji, H. Moriwaki, Y. Muto Apoptosis in human hepatoma cell line induced by 4,5-didehydro geranylgeranoic acid (acyclic retinoid) via down-regulation of transforming growth factor-alpha Biochem Biophys Res Commun 219 1996 100 104
36. R-X. Shao, M. Otsuka, N. Kato, H. Taniguchi, Y. Hoshida, M. Moriyama, T. Kawabe, M. Omata Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways Gastroenterology 128 2004 86 95
37. E.R. Vickers, A. Kasza, I.A. Kurnaz, A. Seifert, L.A. Zeef, A. O'Donnell, A. Hayes, A.D. Sharrocks Ternary complex factor-serum response factor complex-regulated gene activity is required for cellular proliferation and inhibition of apoptotic cell death Mol Cell Biol 24 2004 10340 10351
38. M. Katoh WNT and FGF gene clusters (review) Int J Oncol 21 2002 1269 1273
39. N. Asada, Y. Tanaka, Y. Hayashido, S. Toratani, M. Kan, M. Kitamoto, T. Nakanishi, G. Kajiyama, K. Chayama, T. Okamoto Expression of fibroblast growth factor receptor genes in human hepatoma-derived cell lines In Vitro Cell Dev Biol Anim 39 2003 321 328
40. S. Ogasawara, H. Yano, A. Iemura, T. Hisaka, M. Kojiro Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines Hepatology 24 1996 198 205
41. J.G. Christensen, A.J. Gonzales, R.C. Cattley, T.L. Goldsworthy Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by nongenotoxic carcinogens Cell Growth Differ 9 1998 815 825
42. S. Hasmall, G. Orphanides, N. James, W. Pennie, K. Hedley, A. Soames, I. Kimber, R. Roberts Downregulation of lactoferrin by PPARα ligands role in perturbation of hepatocyte proliferation and apoptosis Toxicol Sci 68 2002 304 313
43. J.M. Peters, R.C. Cattley, F.J. Gonzalez Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 Carcinogenesis 18 1997 2029 2033
44. K. Yoshizawa, D.P. Cioca, S. Kawa, E. Tanaka, K. Kiyosawa Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines Cancer 95 2002 2243 2251
45. M. Toyoda, H. Takagi, N. Horiguchi, S. Kakizaki, K. Sato, H. Takayama, M. Mori A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells Gut 50 2002 563 567